These data also suggest novel therapeutic approaches for a variety of other pathologies, such as multiple sclerosis, atherosclerosis and several types of cancers, that may be impacted by dopamine-driven CCR5 expression. This evidence concerns the gene CCR5 and atherosclerosis.